As with its adult vaccine, Pfizer/BioNTech was the first to cross the finish line and offer a Food and Drug Administration-authorized COVID-19 vaccine to children ages 5 through 11. Here, we describe how it’s different from its grown-up cousin and what experts are saying about who should get it.
Featured Posts
How Many Died as a Result of Capitol Riot?
Rep. Alexandria Ocasio-Cortez said the Jan. 6 attack on the Capitol resulted in “almost 10 dead.” Four people died that day, and five others — all law enforcement officers — died days, weeks and even months later. Here we lay out what is publicly known about the circumstances surrounding those deaths.
Biden Spins Facts on Framework
FactChecking Biden’s Town Hall
Colin Powell’s COVID-19 Death Followed Cancer Diagnosis, Treatment
Former Secretary of State Colin Powell died from complications of COVID-19. Although he was fully vaccinated, he was also 84 years old and was a cancer patient who had undergone treatment for multiple myeloma — factors that put him at higher risk of a serious breakthrough illness. His death does not mean the COVID-19 vaccines don’t work, as many social media posts suggest.
Already Had COVID-19? Vaccines Boost Immunity, Not ‘Wipe Out’ Antibodies
PhRMA Ad Misleads on Medicare Drug Negotiation Legislation
Merck, Pfizer COVID-19 Antivirals Different From Ivermectin
Merck and Pfizer are each developing a new oral antiviral drug that might prevent or treat COVID-19. The pills are very different from the antiparasitic medication ivermectin, contrary to claims online that they are “suspiciously similar” or that the companies are “repackaging” ivermectin in a ploy to increase profits.









